Patents by Inventor Didier Pelaprat

Didier Pelaprat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors
    Patent number: 9809624
    Abstract: The invention relates to a new neurotensin analogue, or a salt thereof, useful for targeting to neurotensin receptor-positive tumors, like ductal pancreatic adenocarcinoma, exocrine pancreatic cancer, invasive ductal breast cancers, colon adenocarcinoma, small cell lung carcinoma, Ewing sarcoma, meningioma, medulloblastoma and astrocytoma.
    Type: Grant
    Filed: July 16, 2010
    Date of Patent: November 7, 2017
    Assignees: INSERM (Institut National de la Sante et de la Recherche Medicale), IASON GmbH
    Inventors: Anne Gruaz, Didier Pelaprat, Jacques Barbet, Dirk Tourwe
  • NEUROTENSIN ANALOGUES FOR RADIOISOTOPE TARGETING TO NEUROTENSIN RECEPTOR-POSITIVE TUMORS
    Publication number: 20120207676
    Abstract: The invention relates to a new neurotensin analogue, or a salt thereof, useful for targeting to neurotensin receptor-positive tumors, like ductal pancreatic adenocarcinoma, exocrine pancreatic cancer, invasive ductal breast cancers, colon adeno-carcinoma, small cell lung carcinoma, Ewing sarcoma, meningioma, medulloblastoma and astrocytoma.
    Type: Application
    Filed: July 16, 2010
    Publication date: August 16, 2012
    Applicant: INSERM (Institut National de la Sante et de la Recherche Medicale)
    Inventors: Anne Gruaz-Guyon, Didier Pelaprat, Jacques Barbet, Dirk Tourwe